Convertible Notes Resolved
MTY has finalised an agreement with holders of MTY Convertible Notes ...
Analyst Report and Interactive Roadshow Released
... first online Interactive Investor Roadshow eKit ...
Removal of $1.5M potential liability
MTY and Cell Signals Inc., have signed an amendment to the IP Agreement
Midkine Strategy
...MTY completed its Midkine Commercial Developement Strategy...
Results of General Meeting 5 May 2009
Results of General Meeting of Members ...
Midkine Test Validated
... Revenue Generating Veterinary Midkine Test Validated....
MTY Shareholder News October 2008
MTY Shareholder News
Major US Patent Granted
...“Agents Comprising Midkine or an Inhibitor Thereof as Active Ingredient”...


Cellmid Ltd (CDY):

Last Price
Announcement - Revenue Generating Veterinary Midkine Test Validated

December 2008, Sydney, Australia: Medical Therapies Limited has completed independent validation of its veterinary cancer diagnostic test which relies on measuring blood midkine levels for the detection of cancer in mammals.

To read more.... Download pdf here
© Cellmid Ltd
Share Trading Policy | Privacy | Contact Us
Web Developer Sydney
 Web design company
Cellmid Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@cellmid.com.au